Skip to content

DBD

Diebold Nixdorf, Incorporated

NYSE · USTechnologySoftware - Application
$85.34-0.39%

Price as of Jul 20, 2026

DBD financials

Diebold Nixdorf, Incorporated financial statements

Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.

Metric2025202420232022
Income statement
Revenue$3.8B$3.8B$3.8B$3.5B
Cost of revenue$2.8B$2.8B$2.9B$2.7B
Gross profit$1.0B$920.0M$876.2M$757.3M
Operating expenses$668.8M$737.9M$789.3M$969.0M
Operating income$334.6M$182.1M$86.9M-$211.7M
Net income$94.6M-$16.5M$1.4B-$581.4M
EBITDA$334.8M$334.9M$275.0M-$113.4M
Basic EPS$2.57$-0.44$21.38$-7.44
Diluted EPS$2.54$-0.44$21.38$-7.44
Balance sheet
Cash & equivalents$387.3M$296.2M$550.2M$307.4M
Total assets$3.9B$3.5B$4.2B$3.1B
Total liabilities$2.7B$2.6B$3.1B$4.4B
Stockholders’ equity$1.1B$929.8M$1.1B-$1.4B
Total debt$1.2B$1.0B$1.4B$2.7B
Net debt$786.8M$750.9M$807.2M$2.4B
Cash flow
Operating cash flow$300.7M$149.2M-$257.0M-$387.9M
Capital expenditure-$37.4M-$17.4M-$24.9M-$53.1M
Free cash flow$263.3M$131.8M-$281.9M-$441.0M
Dividends paid$0.00$0.00$0.00$0.00
Share repurchases-$130.7M$0.00$0.00$0.00